Search

everythinglearnresearchcommunity

for

Search:↓

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

Antituberculous drugs improved symptoms in a woman with lupus and myositis.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

A woman with lupus and severe nerve damage improved with specific treatments.

Some diets and supplements might help with skin disorders, but their effectiveness varies and more research is needed.

Digital gangrene can be a rare first sign of late-onset systemic lupus erythematosus.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Lupus can cause hair loss and nail changes, with treatments available for both.

A woman with lupus had rare severe symptoms but improved with treatment.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Celiac disease can cause skin problems that may get better with a gluten-free diet.

Treating cystoid macular oedema in uveitis is difficult and risky.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Lupus can look like hair loss from alopecia areata but needs different treatment.

Erosive pustular dermatosis of the scalp is a type of skin inflammation often confused with other conditions, requiring continuous treatment.

Some skin disorders might be linked to H. pylori infection, but more research is needed to confirm this.

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.

Careful management of blood thinners is crucial for lupus patients with APS.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.